30 April 2020
Cenkos Securities plc
("Cenkos" or the "Company")
Director Shareholding
Cenkos was notified on 30 April 2020 that, on that same day, Andy Boorman, a non-executive director of the Company, purchased 20,000 ordinary shares of 1p each in the Company ("Ordinary Shares") at a price of 50.52 pence per Ordinary Share.
Following the transaction, Andy Boorman is interested in a total of 88,152 Ordinary Shares, representing 0.16% of the Company's issued ordinary share capital.
The notification below, made in accordance with the Market Abuse Regulation, provides further details in relation to the purchase of Ordinary Shares.
NOTIFICATIONS AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
a)
|
Name
|
Andy Boorman |
|||
2
|
Reason for the notification
|
||||
a)
|
Position/status
|
PDMR (Non-Executive Director) |
|||
b)
|
Initial notification /Amendment
|
Initial notification |
|||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
Cenkos Securities plc |
|||
b)
|
LEI
|
213800ALVRC52VN3I821
|
|||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
a)
|
Description of the financial instrument, type of instrument |
Ordinary shares of 1p each |
|||
|
|
||||
Identification code |
GB00B1FLHR07 |
||||
|
|
||||
b)
|
Nature of the transaction
|
Purchase of ordinary shares |
|||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
50.52p |
20,000 |
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
n/a single transaction |
|||
|
|
||||
- Aggregated volume |
|
||||
|
|
||||
- Prices |
|
||||
|
|
||||
e)
|
Date of the transaction
|
30 April 2020 |
|||
f)
|
Place of the transaction
|
AIMX |
For further information, please contact: |
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|